Home › Funds › Frazier Life Sciences Management, L.P. › TLGYF
Frazier Life Sciences Management, L.P. position in TLGYF
TCGX ACQUISITION CORP
Frazier Life Sciences Management, L.P. reported holding 300,000 shares of TLGYF (TCGX ACQUISITION CORP) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.10% of its reported portfolio and ranking #42 among its reported holdings. Frazier Life Sciences Management, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s TLGYF position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in TLGYF in Q3 2026 at 300,000 shares (US$3.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 300.00K | $3.75M | New |
About TLGYF and 13F data
TLGYF (TCGX ACQUISITION CORP) is a company whose sector is not yet classified in our data. 36 other funds we track also report a position in TLGYF — the largest reported positions include BVF INC/IL (US$6.3M), Squadron Capital Management LLC (US$4.6M), Spruce Street Capital LP (US$3.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TLGYF
- BVF INC/IL 500.00K sh · $6.25M · Q3 2026
- Squadron Capital Management LLC 370.22K sh · $4.63M · Q3 2026
- Spruce Street Capital LP 300.00K sh · $3.75M · Q3 2026
- Paradigm Biocapital Advisors LP 300.00K sh · $3.75M · Q3 2026
- Commodore Capital LP 300.00K sh · $3.75M · Q3 2026
- Venrock Adviser, LLC 300.00K sh · $3.75M · Q3 2026
- Redmile Group, LLC 299.86K sh · $3.75M · Q3 2026
- EcoR1 Capital, LLC 250.00K sh · $3.13M · Q3 2026
- Trails Edge Capital Partners, LP 250.00K sh · $3.13M · Q3 2026
- Nan Fung Group Holdings Ltd 200.00K sh · $2.50M · Q3 2026
- Caligan Partners LP 200.00K sh · $2.50M · Q3 2026
- Samsara BioCapital, LLC 100.00K sh · $1.25M · Q3 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held TLGYF?
Frazier Life Sciences Management, L.P. has disclosed TLGYF holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Frazier Life Sciences Management, L.P.'s current position in TLGYF?
As of Q3 2026, Frazier Life Sciences Management, L.P. holds 300.00K shares of TLGYF (TCGX ACQUISITION CORP), valued at $3.75M, representing 0.10% of its reported portfolio and ranking #42.
Has Frazier Life Sciences Management, L.P. been buying or selling TLGYF?
In the latest 13F filing (Q3 2026), Frazier Life Sciences Management, L.P. newly opened its position in TLGYF.
Which other funds hold TLGYF?
Other major institutional holders of TLGYF include BVF INC/IL, Squadron Capital Management LLC, Spruce Street Capital LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.